|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 213/75 | |
| C07D 405/12 | |||
| C07D 405/14 | |||
| C07D 413/14 | |||
| A61K 31/4427 | |||
| A61K 31/44 | |||
| A61P 43/00 |
| (11) | Number of the document | 2980077 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15182081.8 |
| Date of filing the European patent application | 2009-03-25 | |
| (97) | Date of publication of the European application | 2016-02-03 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 40776 P | 2008-03-31 | US |
| (72) |
HADIDA-RUAH, Sara, US
MILLER, Mark, US
ZHOU, Jinglan, US
BEAR, Brian, US
GROOTENHUIS, Peter, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (54) | PYRIDYL DERIVATIVES AS CFTR MODULATORS |
| PYRIDYL DERIVATIVES AS CFTR MODULATORS |